Lucy Lu

Filings by Lucy Lu span 3 companies, the busiest being Fortress Biotech, Inc., Avenue Therapeutics, Inc. and Veru Inc. Over a trading history stretching from 22 June 2012 to 1 January 2025, the count stands at 19 filings.

Purchases make up the whole of the open-market record (11 purchases, €191k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants.

A typical purchase (the median) is worth €15k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 3 January 2025 with a share grant in Fortress Biotech, Inc. The last purchase on record was published on 14 February 2023, which is 1,348 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.